Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Bigner

Showing results (301-310 of 373) with videos related to

Pageof 38
Sort By:
British Journal of Cancer|June 1, 1995
Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcomaS M Castellino, H S Friedman, G B Elion, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1989
Relationship of the demonstration of intermediate filament protein to kinetics of three human neuroepithelial tumor cell lines. Lack of neural-related proteins in most cells in S phase: a double-labeled immunohistochemical study on matrix culturesN Ibayashi, M M Herman, J C Boyd, et al.
Cancer Research|May 15, 1988
Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6Y Lee, D E Bullard, P A Humphrey, et al.
Neurosurgery|February 1, 1990
L-buthionine-sulfoximine-mediated radiosensitization in experimental interstitial radiotherapy of intracerebral D-54 MG glioma xenografts in athymic miceB E Lippitz, E C Halperin, O W Griffith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in ratsA B Heimberger, G E Archer, R E McLendon, et al.
Cancer Chemotherapy and Pharmacology|April 29, 1998
Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agentsC A Coggins, G B Elion, P J Houghton, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Development of a model of melphalan-induced gastrointestinal toxicity in miceS Castellino, G B Elion, O W Griffith, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumorsM L Hanley, G B Elion, O M Colvin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosoureaS N Kurpad, M E Dolan, R E McLendon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitisD D Bigner, G E Archer, R E McLendon, et al.
Pageof 38

Showing results (301-310 of 373) with videos related to

Sort By:
Pageof 38
British Journal of Cancer|June 1, 1995
Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcomaS M Castellino, H S Friedman, G B Elion, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1989
Relationship of the demonstration of intermediate filament protein to kinetics of three human neuroepithelial tumor cell lines. Lack of neural-related proteins in most cells in S phase: a double-labeled immunohistochemical study on matrix culturesN Ibayashi, M M Herman, J C Boyd, et al.
Cancer Research|May 15, 1988
Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6Y Lee, D E Bullard, P A Humphrey, et al.
Neurosurgery|February 1, 1990
L-buthionine-sulfoximine-mediated radiosensitization in experimental interstitial radiotherapy of intracerebral D-54 MG glioma xenografts in athymic miceB E Lippitz, E C Halperin, O W Griffith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in ratsA B Heimberger, G E Archer, R E McLendon, et al.
Cancer Chemotherapy and Pharmacology|April 29, 1998
Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agentsC A Coggins, G B Elion, P J Houghton, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Development of a model of melphalan-induced gastrointestinal toxicity in miceS Castellino, G B Elion, O W Griffith, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumorsM L Hanley, G B Elion, O M Colvin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosoureaS N Kurpad, M E Dolan, R E McLendon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitisD D Bigner, G E Archer, R E McLendon, et al.
Pageof 38